Microbial Chemistry Research Foundation

The Microbial Chemistry Research Foundation, widely known as the Institute of Microbial Chemistry (BIKAKEN), is a prestigious Japanese non-profit research organization focused on the discovery of bioactive compounds from microorganisms. Founded in 1958 by the renowned scientist Dr. Hamao Umezawa, the institute has been instrumental in the discovery of numerous life-saving antibiotics and anticancer agents, including kanamycin and bleomycin. MCRF operates as a specialized R&D engine that screens microbial metabolites to identify novel small molecules for challenging medical needs. The foundation maintains extensive research facilities in Tokyo and Shizuoka, where it conducts basic and applied research in microbiology and organic chemistry. Its business model primarily involves the discovery and early-stage development of compounds which are then licensed to global pharmaceutical partners for clinical development and commercialization.